Skip to content

Hounsfield Units from HRCT as a marker of bone mineral density reduction in systemic sclerosis – a retrospective analysis

Hounsfield Units from HRCT as a marker of bone mineral density reduction in systemic sclerosis – a retrospective analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037348
Enrollment
100
Registered
2025-07-04
Start date
2025-07-03
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M34.0

Interventions

Group 1: Adult patients with systemic sclerosis who underwent HRCT (High-resolution computed tomography) and had a concurrent dual-energy X-ray absorptiometry (DXA) scan available

Sponsors

Justus-Liebig-Universität Giessen, Campus Kerckhoff
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of systemic sclerosis according to the 2013 ACR/EULAR classification criteria Available HRCT of the thorax DXA scan performed within ±6 months of the HRCT examination

Exclusion criteria

Exclusion criteria: Missing HRCT or DXA scan, or a time interval between the two examinations exceeding ±6 months Anatomical or pathological alterations that could significantly distort bone density measurements by HRCT or DXA, such as severe degenerative spinal changes or osteolytic/osteoblastic lesions Presence of known secondary causes of osteoporosis (excluding SSc), including prolonged high-dose corticosteroid therapy (>7.5 mg prednisolone equivalent daily for more than 3 months), metabolic bone diseases (e.g., primary hyperparathyroidism, renal osteodystrophy), multiple myeloma, or severe endocrine disorders (e.g., untreated Cushing’s syndrome, untreated hypogonadism, uncontrolled diabetes mellitus) Inadequate image quality of HRCT or DXA Missing or incomplete patient data

Design outcomes

Primary

MeasureTime frame
Correlation between HU values from HRCT and BMD values from DXA Diagnostic agreement between HU-based and DXA-based osteoporosis classifications Determination of an optimal HU cutoff value for the identification of osteoporosis

Secondary

MeasureTime frame
Influence of clinical variables on HU values and BMD Reproducibility of HU measurement (interrater reliability) Association between low HU values and osteoporotic fractures

Countries

Germany

Contacts

Public ContactNils Schulz

Justus-Liebig-Universität Giessen, Campus Kerckhoff

n.schulz@kerckhoff-klinik.de06032/996-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026